• PPACK Dihydrochloride: Mapping Thrombin Control

  2026-08-25

  PPACK Dihydrochloride provides a high-affinity, irreversible thrombin clamp for dissecting platelet and coagulation phenotypes. This article develops a pathway-aware assay framework that pairs thrombin inhibition with insights from selective P2X1 blockade.

• EdU Flow Cytometry Assay Kits (Cy5)

  2026-08-24

  EdU Flow Cytometry Assay Kits (Cy5) measure S-phase DNA synthesis through copper-catalyzed azide-alkyne cycloaddition (CuAAC) and Cy5 fluorescence. The K1078 workflow provides a DNA synthesis endpoint for flow cytometry cell proliferation assays while avoiding harsh DNA denaturation.

• DED Assembly and Caspase-8 Signaling in Apoptosis

  2026-08-23

  The 2024 Nature Communications study resolves atomic-level FADD–procaspase-8–cFLIP assemblies using X-ray crystallography and cryo-electron microscopy. Its structural and mutational evidence explains how limited caspase-8 activation can support survival while coordinating apoptotic and necroptotic signaling through RIPK1.

• Lovastatin: A Mechanism-First Assay Guide

  2026-08-22

  Lovastatin is an HMG-CoA reductase inhibitor with effects that extend from cholesterol biosynthesis to proliferation, apoptosis, macrophage efferocytosis, and tissue remodeling. This mechanism-first guide connects those endpoints with a plant-development study to improve assay design without overstating cross-domain evidence.

• CDK4/6–BET Synergy in Pancreatic Cancer

  2026-08-21

  Gu et al. show that combining the CDK4/6 inhibitor palbociclib with the BET inhibitor JQ1 suppresses pancreatic ductal adenocarcinoma more effectively than either agent alone. The study is especially informative because it explains how BET inhibition counteracts CDK4/6 inhibitor-associated epithelial-to-mesenchymal transition through GSK3β-mediated Wnt/β-catenin and TGF-β/Smad signaling.

• CHI3L1-IN-5 Workflow for Neuroinflammation

  2026-08-20

  Build a translational workflow around CHI3L1-IN-5 (Compound Z17) by connecting target-pathway readouts with astrocyte Aβ uptake and lysosomal assays. The guide also separates this CNS application from an independently reported ALDH2 activator that shares the Z17 designation, preventing a common interpretation error.

• Moxidectin: From Parasite Control to Antifungal Synergy

  2026-08-20

  Moxidectin is a macrocyclic lactone anthelmintic with established veterinary antiparasitic value and an emerging role as a polyene-sensitizing research tool. This guide translates its ergosterol-linked antifungal findings into practical workflows for combination screening, biofilm assays, mechanistic validation, and troubleshooting.

• Benzyl-activated Streptavidin Magnetic Beads in I/R Assays

  2026-08-19

  Benzyl-activated Streptavidin Magnetic Beads convert biotin-dependent recognition into a rapid, magnetically separated workflow for annexin-V, protein, and nucleic-acid capture. This article connects an early cell-death measurement strategy from cardiac ischemia–reperfusion research with practical ex vivo enrichment, immunoprecipitation, and screening workflows.

• Recombinant Mouse IFN-γ in MASH-HCC Assays

  2026-08-19

  Use Recombinant Mouse IFN-γ as a defined stimulus to separate defects in tumor antigen presentation from defects in immune-cell function. This practical workflow supports MASH-HCC, macrophage, TH1, and antiviral assay development while highlighting dose, timing, endotoxin, and species-compatibility controls.

• Wnt-C59: Practical PORCN Inhibition Workflows

  2026-08-18

  Wnt-C59 gives researchers a controlled way to test how PORCN-dependent Wnt secretion shapes tumor phenotypes, reporter activity, and stem-cell communication. This guide translates its mechanism into cell-based, exosome, and translational oncology workflows while emphasizing controls, dosing logic, and troubleshooting.

• Gasdermin C Rewires PDAC Stemness and Immunity

  2026-08-18

  A 2024 Advanced Science study identifies GSDMC as a nuclear regulator of pancreatic ductal adenocarcinoma stemness, metastasis, and immune evasion, rather than only a pore-forming pyroptosis protein. Its ADAM17-dependent cleavage and nuclear translocation provide mechanistic targets that may improve responses to KRASG12D inhibition and PD-1 blockade.

• Hexa-Acylated LPS and Cancer Immunotherapy Response

  2026-08-17

  This Nature Microbiology study shows that the functional structure of gut microbiota-derived lipopolysaccharide, rather than bacterial taxonomy alone, can influence anti-PD-1 immunotherapy response. Human metagenomics and mouse experiments identify hexa-acylated LPS–TLR4 signaling as a candidate biomarker and preclinical enhancer of antitumor immunity.

• Epinephrine in Local Anesthesia: Evidence and Limits

  2026-08-17

  This 1986 review explains how epinephrine improves local anesthesia through vasoconstriction, prolonged anesthetic action, hemostasis, and reduced systemic uptake of local anesthetics. Its central practical conclusion is that 1:200,000 epinephrine may provide an effective balance between anesthetic performance and systemic risk in many dental situations, while concentration, dose, injection technique, and patient factors remain decisive.

• Protease Inhibitor Cocktail for Plant Protein Workflows

  2026-08-16

  Protect plant proteins from harvest through Western blotting, co-immunoprecipitation, pull-down, and kinase assays with broad-spectrum, EDTA-free inhibition. This workflow translates the NSP2–MYB40 symbiosis findings into practical strategies for preserving transcription factors, signaling proteins, and phosphoprotein readouts.

• Ivermectin: Designing Mechanism-First Assays

  2026-08-15

  Ivermectin is a broad-spectrum anti-parasitic research compound best evaluated through mechanism-aligned assay design. This article connects parasite neuromuscular assays with lessons from GSDMC research in pancreatic cancer while clearly separating established evidence from exploratory cross-domain applications.

453 records 7/31 page Previous Next First page 上5页 678910 下5页 Last page